Skip to main content

Editorial Board

Editor
Patrik Flammer, BMC, UK

New Content ItemDr Patrik Flammer is a cross-journal editor for BMC Medical Genomics and Genome Medicine and is based in the London office.

Dr Flammer earned a Bachelor’s degree in Biology and Biochemistry and a Master’s degree in molecular and cellular biology from the University of Zurich. For his Master’s project he worked on recombinant adenoviral vectors (oncolytic vectors for melanoma). He completed his DPhil at the University of Oxford where he was working on genetics and epidemiology of human intestinal parasites. His postdoctoral research extended this to include aspects of ancient DNA and epidemiology of infections in past populations.

Assistant Editor
Arwa Tawfiq, BMC, UK

Senior Editorial Board Members
Youping Deng, University of Hawaii, John A. Burns School of Medicine, USA

Youping Deng ProfileProf Youping Deng is a tenured full professor and Director of the Bioinformatics Core Facility at the John A. Burns School of Medicine at the University of Hawaii. He is also Co-Director, Genomics and Bioinformatics Shared Resource, at University of Hawaii Cancer Center. 

Before joining University of Hawaii in 2016, he was Director of Bioinformatics and Biostatistics,  Associate Professor at Rush University Medical Center. He received his Ph.D. from Peking Union Medical College and finished his postdoctoral training in Wayne State University. From 2004 to 2008, he was a tenure track assistant professor at the University of Southern Mississippi. He has published more than 210 papers in peer-reviewed journals. 


Isabelle Schrauwen, Columbia University, USA

New Content Item (1)Dr Isabelle Schrauwen joined the Editorial Board of BMC Medical Genetics as an Associate Editor in 2017 and moved to BMC Medical Genomics as a Senior Editorial Board member in 2020. She received her PhD in Biomedical Sciences at the University of Antwerp, Belgium and is currently an Assistant Professor at the Center for Statistical Genetics at Columbia University, NYC, USA.

Dr Schrauwen’s research focuses on examining the genetic basis and pathogenic mechanisms of sensory and neurological disorders. She implements both family-based and population-based methods to identify genetic factors involved in these disorders. Some of these children endure years-long diagnostic odysseys of trial-and-error testing with inconclusive results and misdirected treatments. She is dedicated to track down their molecular causes by integrating various “-omics” technologies, including genomics, transcriptomics and epigenomics. Dr Schrauwen continues to build a body of knowledge that can lead to improvements in disease management and treatment.


Konstantinos Voskarides, University of Nicosia Medical School, Nicosia, Cyprus 

New Content ItemDr Konstantinos Voskarides is an Assistant Professor of Genetics and Molecular Biology at the University of Nicosia Medical School.

Dr Voskarides holds a BSc in Biology from Aristotle University of Thessaloniki and a PhD in Molecular Biology and Genetics from University of Cyprus. He is currently a Senior Editor at the Springer journals “BMC Medical Genomics” and “Journal of Molecular Evolution”. Dr Voskarides has expertise on medical and evolutionary genetics. He contributed to the discovery of new genes causing familial renal diseases and he also deciphered the genetic origins of Greek-Cypriots. Between 2010-2015 he contributed to the establishment of the first Biobank in Cyprus and afterwards the first zebrafish facility in Medical School of University of Cyprus. He recently discovered a possible link between cancer incidence and previous evolutionary adaptations, a study that gained a lot of attendance by news media in 2018.

His current research is mainly focused on comparative and evolutionary genetics of cancer genes, having introduced zebrafish as an animal model to experimental evolution. He is also interested on analysis of GWAS data regarding rheumatic and psychiatric diseases. Dr Voskarides has authored 58 articles since 2021 in prestigious journals, he has an h-index 23, and he is the Editor of a book in Spriger Publishing Group.


Lidia Larizza, Istituto Auxologico Italiano, Italy

New Content ItemProf Lidia Larizza is the Research  Director of the Medical Cytogenetics & Human Molecular Genetics Lab at the Centro di Tecnologie Biomediche, IRCSS Istituto Auxologico Italiano, Milano, Italy. Previously she was Professor of Medical Genetics, founder and Director of the Post-lauream School in Medical Genetics, University of Milan. She has been President of European Cytogenetics Association (ECA) and President of the Italian Society of Hunan Genetics (SIGU), and she is honorary member of both Associations.

Prof Larizza's main current research interests are: (1) Mendelian disorders of chromatin regulators, such as cohesinopathies, Rubinstein-Taybi (RSTS) and related neurodevelopmental disorders; the iPSC-neuronal model is increasingly exploited to unveil RSTS biomarkers, dysregulated gene networks underlying cognitive impairment and candidate “epi-drugs” for therapeutics. (2) Imprinting disorders affecting growth and the aetiology of MLID (Multilocus Imprinting Disturbance)  investigated by using multiple approaches of epigenetic/epigenomic research. (3) Longlasting interest in cancer research is at the foundation of studies on genomic and chromosomal instability syndromes with Cancer Predisposition, including Neurofibromatosis type 1, Rothmund-Thomson, Poikiloderma with Neutropenia and Hereditary Fibrosis Poikiloderma.   

Prof Larizza is the author of 280 publications and 30 monographs.


Valerio Napolioni, University of Camerino, Italy

New Content ItemDr Valerio Napolioni is an Associate Professor of Molecular Biology at the School of Biosciences and Veterinary Medicine, University of Camerino, Italy, where he is leading the “Genomic and Molecular Epidemiology (GAME)” lab, dealing with the analysis of genomic BIG-DATA and personalized medicine.

Dr Napolioni holds a PhD in Genetics from the University of Camerino, Italy, working on the genetics of complex traits, focusing on both human longevity and autism. His interest in neuropsychiatric traits led him to continue working on the genetics of autism, first as a post-Doc fellow at the Molecular Psychiatry Lab., University “Campus Bio-Medico” of Rome, and then as an Adjunct Faculty/Visiting researcher (2011-2012) at the Translational Genomics Research Institute (TGen), Phoenix, AZ, U.S.A. In 2013 he became the Technical Director of the NGS core at the University of Perugia, Italy. From 2015 he joined the Department of Neurology and Neurological Sciences of Stanford University School of Medicine, Palo Alto, CA, first as a post-Doc (2015-2017), and later (2017-2020) as Instructor in Neurology and Neurological Sciences, pursuing his strong research interest in the genetics of human neuropsychiatric and behavioral traits.

Currently, his large and solid expertise in genomic and molecular Epidemiology is leading him to tackle a myriad of different scientific issues, from human X-chromosome analysis to the genome-wide analysis of neuropsychiatric traits, and from global evolutionary/human adaptation-related issues to the pan-genome analysis of clinically relevant bacterial species.


Federico Canzian, Deutsches Krebsforschungszentrum (DKFZ), Germany

Federico CanzianDr Federico Canzian was a member of the Editorial Board of BMC Genetics from 2008 to 2020, first as an Associate Editor and then as Section Editor. He is a Senior Editorial Board member for BMC Medical Genomics since 2021.
 
Dr Canzian was trained as a cancer geneticist and at present leads the Genomic Epidemiology Group at the German Cancer Research Center (DKFZ) in Heidelberg, Germany.
 
Dr Canzian’s research focuses on the role of genetic polymorphisms as cancer risk factors. He has worked in the context of animal models, family studies, association studies based on candidate genes and, more recently, genome-wide association studies. He has a longstanding experience in working in the context of complex multicentric projects, including the European Prospective Investigation on Cancer (EPIC; http://epic.iarc.fr/) and the NCI Breast and Prostate Cancer Cohort Consortium (BPC3; http://epi.grants.cancer.gov/BPC3/). More recently he initiated and coordinates the PANcreatic Disease ReseArch (PANDoRA; https://pandoraconsortium.wixsite.com/pandora) consortium and the International Multiple Myeloma rESEarch (IMMEnSE) consortium, international networks to study genetics of pancreatic cancer and multiple myeloma, respectively.
 
Dr Canzian has authored over 300 papers in peer-reviewed journals.


Generoso Andria, University of Naples, Italy 

Ping An, Center for Cancer Research, National Cancer Institute, USA
 


Senior Editorial Board Members
Ping An, National Cancer Institute, USA
Generoso Andria, University of Naples, Italy
Federico Canzian, German Cancer Research Centre, Germany
Youping Deng, University of Hawaii Cancer Center, USA
Lidia Larizza, Istituto Auxologico Italiano, Italy
Valerio Napolioni, University of Camerino, Italy
Isabelle Schrauwen, Columbia University, USA
Konstantinos Voskarides, University of Nicosia, Cyprus

Editorial Board Members
Animesh Acharjee, Institute of Cancer and Genomic Sciences, University of Birmingham, UK
Sally Adebamowo, University of Maryland School of Medicine, USA
Jose Agundez, Universidad de Extremadura, Spain
Shandar Ahmad, Jawaharlal Nehru University, India
Touati Benoukraf, Memorial University of Newfoundland, Canada
Weimin Bi, Baylor Genetics, USA
Hoh Boon-Peng, UCSI University, Malaysia
Tao Cai, NIDCR, NIH, USA
Sergi Castellvi-Bel, Institut d'Investigacions Biomediques August Pi i Sunyer, Spain
Imen Chakchouk, Baylor College of Medicine, USA
Kelvin Chan, Queen Mary Hospital, China
Kumardeep Chaudhary, Icahn School of Medicine at Mount Sinai, USA
William C Cho, Queen Elizabeth Hospital, Hong Kong
Samuel Chong, National University of Singapore, Singapore
Brian Hon-Yin Chung, Department of Paediatrics & Adolescent Medicine, The University of Hong Kong Queen Mary Hospital, Hong Kong
Rafael Contreras-Galindo, Hormel Institute/ university of Minnesota-Mayo Clinic, USA
Fabio Coppedè, University of Pisa, Italy
Manuel Corpas, Universidad Internacional de La Rioja, UK
Hengmi Cui, Yangzhou University, China
Swapan Kumar Das, Wake Forest School of Medicine, USA
Bhavana Dave, University of Nebraska Medical Center, USA
Marco De Martino, Institute for Experimental Endocrinology and Oncology (IEOS) “G. Salvatore”, National Research Council (CNR), Italy
Margaret Deangelis, University at Buffalo, USA
Barthelemy Diouf, Saint Jude Children's Research Hospital, USA
Vijaya R. Dirisala, Vignan's Foundation for Science, Technology & Research University, India
Shiwei Duan, Ningbo University, China
Nashwa El-Khazragy, Faculty of Medicine, Ain Shams University, Egypt
Joanna Elson, University of Newcastle, UK
Segun Fatumo, London School of Hygiene and Tropical Medicine, United Kingdom
Victor Faundes, Universidad de Chile, Chile
Brooke Fridley, H Lee Moffitt Cancer Center and Research Institute, USA
Xiaowu Gai, Keck School of Medicine USC, USA
Jose Garcia-Sagredo, Universidad de Alcalá, Spain
Mara Giordano, Department of Health Sciences, University of Eastern Piedmont, Italy
Jeffrey P Gregg, University of California, Davis, USA
Jin Gu, Tsinghua University, China
Ravindra Gujar, La Jolla Institute for Immunology, USA
Kamlesh Guleria, Guru Nanak Dev University, India
. Gunadi, Universitas Gadjah Mada, Indonesia
Neena Haider, Schepens Eye Research Institute, USA
Samuel Handelman, University of Michigan, USA
Rosline Hassan, Universiti Sains Malaysia, Malaysia
Haiyang Hu, China Pharmaceutical University, China
Qihong Huang, The Wistar Institute, USA
Mark Ibberson, SIB Swiss Institute of Bioinformatics, Switzerland
Ivan Iourov, Mental Health Research Center, Russia
Saumya Shekhar Jamuar, Duke-NUS Medical School, Singapore
James Jarvis, University of Oklahoma College of Medicine, USA
Goodwin Jinesh, H Lee Moffitt Cancer Center, USA
Katherine Johnson, Newcastle University, United Kingdom
Paula Jorge, Centro Hospitalar do Porto, Portugal
Shama Prasada Kabekkodu, Manipal Academy of Higher Education, India
Masayo Kagami, Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo
Theodora Katsila, National Hellenic Research Foundation, Greece
Denise Kay, Wadsworth Center, New York State Department of Health, USA
Sulev Kõks, The Perron Institute for Neurological and Translational Science, Australia
Darren Korbie, Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Australia
Rahul Kumar, Department of Biotechnology, Indian Institute of Technology, India
Vibhor Kumar, Indraprastha Institute of Information Technology, Delhi, India
Hang Fai Kwok, University of Macau, Macao
Kent Lai, University of Utah, USA
Yinglei Lai, The George Washington University, USA
Wei Lan, Guangxi University, China
Scott M Langevin, University of Cincinnati, USA
Keshen Li, Clinical Neuroscience Institute of Jinan University, China
Man Li, University of Utah School of Medicine, USA
Xingnan Li, University of Arizona, USA
Stefano Lise, The Institute of Cancer Research, London, UK
William Lockwood, Memorial Sloan-Kettering Cancer Center, Canada
Marco Lucarelli, Università di Roma, Italy
Milica Keckarevic Markovic, University of Belgrade Faculty of Biology, Serbia
Kirk McManus, University of Manitoba, Canada
Giuseppe Merla, Ospedale Casa Sollievo della Sofferenza, Italy
Kunio Miyake, Department of Health Sciences, University of Yamanashi, Japan
Meysam Moghbeli, Mashhad university of medical sciences, Iran
Michal Mokry, UMC Utrecht, Netherlands
Marlo Moller, Stellenbosch University, South Africa
A K Munirajan, University of Madras, India
Avaniyapuram Kannan Murugan, King Faisal Specialist Hospital and Research Centre, Saudi Arabia
Satya Narayan, University of Florida, USA
Maggie C Ng, Vanderbilt University School of Medicine, USA
Nijiro Nohata, MSD K.K., Japan
Shusuke Numata, Tokushima University, Japan
Gisela Orozco, University of Manchester, UK
Wael Osman, Khalifa University, Abu Dhabi, Utd.Arab.Emir.
Mustafa Özen, Baylor College of Medicine, USA
Ravi Shanker Pandey, The Jackson Laboratory for Genomic Medicine, USA
Zhiyu Peng, BGI Genomics, China
Giovanna Piovani, University of Brescia, Italy
Mehdi Pirooznia, National Heart, Lung, and Blood Institute, National Institutes of Health, USA
Alberto Plaja, Hospital Valle Hebron, Spain
Dimitris Polychronopoulos, AstraZeneca, United Kingdom
Paolo Prontera, Medical Genetics Unit, University and Hospital of Perugia, Perugia, Italy
Chamindie Punyadeera, Griffith University, Australia
Faisal Rezwan, Aberystwyth University, United Kingdom
Jose A Riancho, University of Cantabria, Spain
Vasudha Sambyal, Guru Nanak Dev University, India
Fernando Scaglia, Baylor College of Medicine, USA
Mark Seielstad, University of California San Francisco School of Medicine, USA
Leping Shao, The Affiliated Qingdao Municipal Hospital, Qingdao University, China, People's Republic
Uma Siangphoe, Janssen Research and Development, USA
Roderick Slieker, Leiden University Medical Center, Netherlands
Jennifer A. Smith, Department of Epidemiology, School of Public Health, University of Michigan, USA
Katrina Steiling, Boston University School of Medicine, USA
Adam Stevens, University of Manchester, UK
Prashanth N. Suravajhala, Birla Institute of Scientific Research, India
Y-H. Taguchi, Department of Physics, Chuo University, Japan
Ene-Choo Tan, KK Women's and Children's Hospital, Singapore
Hiromi Tanaka, Indiana University School of Medicine, USA
Kumarasamy Thangaraj, Centre for Cellular and Molecular Biology, India
Chao Tu, The Second Xiangya Hospital, Central South University, China
Turki Turki, King Abdulaziz University, Saudi Arabia
Gilberto Vargas-Alarcon, Instituto Nacional de Cardiología Ignacio Chávez, Mexico
Thirumalaisamy P Velavan, Universitatsklinikum Tubingen, Germany
Franco Vizeacoumar, University of Saskatchewan, Canada
Xuefeng Wang, H. Lee Moffitt Cancer Center & Research Institute, USA
Chen Wang, Mayo Clinic College of Medicine, USA
Jiayin Wang, Xi'an Jiaotong University, China
Jing Wang, Vanderbilt University Medical Center, USA
Kesheng Wang, West Virginia University, USA
Sungho Won, Seoul National University, South Korea
Junfeng Xia, Anhui University, China
Hong-Guang Xie, Nanjing Medical University, China
Mingqing Xu, Harvard University, USA
Jun Yao, M. D. Anderson Cancer Center, USA
Jinsheng Yu, Washington University in St. Louis School of Medicine, USA
Fuli Yu, Baylor College of Medicine, USA
Isabella Zanella, University of Brescia, Italy
Xianquan Zhan, Central South University, China
Fan Zhang, University of Vermont, USA
Jie Zhang, Indiana University, USA
Liye Zhang, ShanghaiTech University, China
Zhen-Yu Zhang, Katholieke Universiteit Leuven, Belgium
Min Zhao, University of sunshine coast, Australia
Yang Zhao, Nanjing Medical University, China
Tong Zhou, University of Nevada, Reno School of Medicine, USA
Marcella Zollino, Università Cattolica del Sacro Cuore, Italy

Editorial Advisors
Timothy Aitman, Imperial College London, UK
Russ Altman, Stanford University, USA
Stephan Beck, University College London, UK
Philip Bernard, University of Utah, USA
Atul Butte, Stanford University, USA
Wei Dai, New York Medical College, USA
Panos Deloukas, The Wellcome Trust Sanger Institute, UK
Johan T den Dunnen, Leiden University Medical Center, Netherlands
Emmanuel Dias-Neto, AC Camargo Cancer Center, Brazil
William Feero, National Human Genome Research Institute, USA
Philippe Froguel, Imperial College London, UK
Teri Klein, Stanford University, USA
Isaac Kohane, Harvard Medical School, USA
Yusuke Nakamura, University of Tokyo, Japan
Brien P Riley, Virginia Commonwealth University, USA
H.-Hilger Ropers, Max-Planck Institute for Molecular Genetics, Germany
Chris Sander, Memorial Sloan-Kettering Cancer Center, USA
Stephen Scherer, The Hospital for Sick Children, Toronto, Canada
Wim van Hul, University of Antwerp, Belgium
Philippe Van Trappen, Academic Hospital Maastricht, Netherlands

Annual Journal Metrics

  • Citation Impact
    3.622 - 2-year Impact Factor (2021)
    3.554 - 5-year Impact Factor (2021)
    0.879 - SNIP (Source Normalized Impact per Paper)
    0.955 - SJR (SCImago Journal Rank)

    Speed
    32 days to first decision for all manuscripts (Median)
    62 days to first decision for reviewed manuscripts only (Median)

    Usage 
    983,595 Downloads (2021)
    1,040 Altmetric mentions (2021)

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal